Evidence map›Paper›PMID 19578119›Full record

ArticleThe Journal of biological chemistry2009

The direct binding of insulin-like growth factor-1 (IGF-1) to integrin alphavbeta3 is involved in IGF-1 signaling.

Jun Saegusa, Satoshi Yamaji, Katsuaki Ieguchi, Chun-Yi Wu, Kit S Lam, Fu-Tong Liu, Yoko K Takada, Yoshikazu Takada

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 101 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jun SaegusaDepartment of Dermatology, University of California Davis School of Medicine, Sacramento, CA 95817, USA.
Satoshi Yamaji
Katsuaki Ieguchi
Chun-Yi Wu
Kit S Lam
Fu-Tong Liu
Yoko K Takada
Yoshikazu Takada
University of California, Davis · US

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura Marcu · 2002 to 2026
$84.9M
Targeting Agents for Human and Canine LymphomaU19CA113298 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI LAM, KIT S · 2005 to 2009
$5.4M
Potential of a dominant-negative FGF mutant as a therapeutic in cancerR01CA131015 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI TAKADA, YOSHIKAZU · 2009 to 2012
$1.3M
NCI NIH HHS CA093373NCI NIH HHS CA113298NCI NIH HHS CA131015NCI NIH HHS P30 CA093373NCI NIH HHS R01 CA131015NCI NIH HHS U19 CA113298
6 · The paper itself

Abstract

It has been proposed that ligand occupancy of integrin alphavbeta3 with extracellular matrix ligands (e.g. vitronectin) plays a critical role in insulin-like growth factor-1 (IGF-1) signaling. We found that expression of alphavbeta3 enhanced IGF-1-induced proliferation of Chinese hamster ovary cells in serum-free conditions (in the absence of vitronectin). We hypothesized that the direct integrin binding to IGF-1 may play a role in IGF-1 signaling. We demonstrated that alphavbeta3 specifically and directly bound to IGF-1 in cell adhesion, enzyme-linked immunosorbent assay-type binding, and surface plasmon resonance studies. We localized the amino acid residues of IGF-1 that are critical for integrin binding by docking simulation and mutagenesis. We found that mutating two Arg residues at positions 36 and 37 in the C-domain of IGF-1 to Glu (the R36E/R37E mutation) effectively reduced integrin binding. Interestingly, although the mutant still bound to IGF1R, it was defective in inducing IGF1R phosphorylation, AKT and ERK1/2 activation, and cell proliferation. Furthermore wild type IGF-1 mediated co-precipitation of alphavbeta3 and IGF1R, whereas the R36E/R37E mutant did not, suggesting that IGF-1 mediates the interaction between alphavbeta3 and IGF1R. These results suggest that the direct binding to IGF-1 to integrin alphavbeta3 plays a role in IGF-1 signaling through ternary complex formation (alphavbeta3-IGF-IGF1R), and integrin-IGF-1 interaction is a novel target for drug discovery.

Indexed as

Cell ProliferationAmino Acid SubstitutionAnimalsCHO CellsCricetinaeCricetulusEnzyme ActivationHumansInsulin-Like Growth Factor IIntegrin alphaVbeta3MiceMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3MutationMutation, MissenseNIH 3T3 Cellsinsulin-like growth factor-1, mouseInsulin-Like Growth Factor IIntegrin alphaVbeta3Mitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Proto-Oncogene Proteins c-aktReceptor, IGF Type 1

Identifiers

PMID19578119
PMCPMC2782004
OpenAlexW2071660679

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.